Jamin W Roh
Overview
Explore the profile of Jamin W Roh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Langel S, Garrido C, Phan C, Travieso T, Kirshner H, DeMarco T, et al.
Immunohorizons
. 2022 Dec;
6(12):851-863.
PMID: 36547390
The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated coronavirus disease (COVID-19) has led to a pandemic of unprecedented scale. An intriguing feature of the...
2.
Milligan E, Olstad K, Williams C, Mallory M, Cano P, Cross K, et al.
Sci Transl Med
. 2022 Dec;
15(685):eadd6383.
PMID: 36454813
The U.S. Food and Drug Administration only gave emergency use authorization of the BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines for infants 6 months and older in June 2022. Yet questions regarding...
3.
Beckman D, Bonillas A, Diniz G, Ott S, Roh J, Elizaldi S, et al.
Cell Rep
. 2022 Oct;
41(5):111573.
PMID: 36288725
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), can induce a plethora of neurological complications in some patients. However, it is still under...
4.
Van Rompay K, Olstad K, Sammak R, Dutra J, Watanabe J, Usachenko J, et al.
PLoS Pathog
. 2022 Apr;
18(4):e1009925.
PMID: 35443018
Early in the SARS-CoV-2 pandemic, there was a high level of optimism based on observational studies and small controlled trials that treating hospitalized patients with convalescent plasma from COVID-19 survivors...
5.
Deere J, Carroll T, Dutra J, Fritts L, Sammak R, Yee J, et al.
Microbiol Spectr
. 2021 Nov;
9(3):e0139721.
PMID: 34817208
Human clinical studies investigating use of convalescent plasma (CP) for treatment of coronavirus disease 2019 (COVID-19) have produced conflicting results. Outcomes in these studies may vary at least partly due...
6.
Verma A, Hawes C, Lakshmanappa Y, Roh J, Schmidt B, Dutra J, et al.
Cell Rep
. 2021 Oct;
37(5):109942.
PMID: 34706272
Anti-viral monoclonal antibody (mAb) treatments may provide immediate but short-term immunity from coronavirus disease 2019 (COVID-19) in high-risk populations, such as people with diabetes and the elderly; however, data on...
7.
Van Rompay K, Olstad K, Sammak R, Dutra J, Watanabe J, Usachenko J, et al.
bioRxiv
. 2021 Sep;
PMID: 34494025
Author Summary: The results of treating SARS-CoV-2 infected hospitalized patients with COVID-19 convalescent plasma (CCP), collected from survivors of natural infection, have been disappointing. The available data from various studies...
8.
Lakshmanappa Y, Roh J, Rane N, Dinasarapu A, Tran D, Velu V, et al.
FEBS Lett
. 2021 Jul;
595(17):2257-2270.
PMID: 34278574
HIV preferentially infects α β CD4 T cells, forming latent reservoirs that contribute to HIV persistence during antiretroviral therapy. However, the properties of α β CD4 T cells in blood...
9.
Van Rompay K, Olstad K, Sammak R, Dutra J, Watanabe J, Usachenko J, et al.
PLoS Pathog
. 2021 Jul;
17(7):e1009688.
PMID: 34228761
There is an urgent need for effective therapeutic interventions against SARS-CoV-2, including new variants that continue to arise. Neutralizing monoclonal antibodies have shown promise in clinical studies. We investigated the...
10.
Lakshmanappa Y, Elizaldi S, Roh J, Schmidt B, Carroll T, Weaver K, et al.
Nat Commun
. 2021 Jan;
12(1):541.
PMID: 33483492
CD4 T follicular helper (T) cells are important for the generation of durable and specific humoral protection against viral infections. The degree to which SARS-CoV-2 infection generates T cells and...